Amy Finan joined the Sabin Vaccine Institute as Chief Executive Officer in April 2016. In her first year as CEO, Ms. Finan led the development and implementation of a strategic plan focusing Sabin on a mission to make vaccines more accessible, enable innovation and expand immunization across the globe.
Prior to joining Sabin, Ms. Finan served as senior vice president responsible for business development at the Biotechnology Innovation Organization (BIO), the world's largest membership organization representing biotechnology companies, academic institutions and state biotechnology centers. During her 11-year tenure at BIO, Ms. Finan played a critical role in expanding the organization’s membership and revenue base and implementing innovative approaches to fundraising, branding, marketing and programming. For two years and simultaneous with her BIO responsibilities, she also served as president of the Biotechnology Institute, an organization founded by BIO to promote life science education.
Prior to BIO, Ms. Finan led corporate communications and investor relations for the former clinical-stage biotechnology company EntreMed Inc for three years. Between 1999 and 2001, she created and implemented Montgomery County, Maryland’s biotech initiative. Ms. Finan began her life sciences career in 1987 when she joined the National Association of Biomedical Research, advancing to a government relations director during her 12-year tenure.
Ms. Finan studied at the London School of Economics & Political Science and graduated with a bachelor’s degree in political science from Trinity College in Washington, D.C. A native of Columbus, Ohio, Ms. Finan has lived in the Washington, DC metropolitan area for more than 30 years and currently resides in Bethesda, Maryland with her family.